Boston Research & Management Inc. decreased its position in shares of Xylem Inc (NYSE:XYL) by 5.9% during the 4th quarter, Holdings Channel reports. The fund owned 58,312 shares of the industrial products company’s stock after selling 3,630 shares during the quarter. Xylem accounts for about 2.0% of Boston Research & Management Inc.’s investment portfolio, making the stock its 18th biggest holding. Boston Research & Management Inc.’s holdings in Xylem were worth $3,976,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Chevy Chase Trust Holdings Inc. boosted its stake in Xylem by 0.9% during the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 197,184 shares of the industrial products company’s stock worth $12,349,000 after acquiring an additional 1,670 shares during the last quarter. Highbridge Capital Management LLC bought a new position in Xylem during the 3rd quarter worth approximately $254,000. Patten Group Inc. boosted its stake in Xylem by 295.6% during the 3rd quarter. Patten Group Inc. now owns 127,490 shares of the industrial products company’s stock worth $2,009,000 after acquiring an additional 95,259 shares during the last quarter. Swiss National Bank boosted its stake in Xylem by 1.2% during the 3rd quarter. Swiss National Bank now owns 661,922 shares of the industrial products company’s stock worth $41,456,000 after acquiring an additional 8,100 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new position in Xylem during the 3rd quarter worth approximately $1,509,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
Xylem Inc (NYSE XYL) opened at $75.23 on Friday. The company has a quick ratio of 1.41, a current ratio of 1.88 and a debt-to-equity ratio of 0.87. Xylem Inc has a one year low of $46.95 and a one year high of $76.81. The firm has a market cap of $13,510.00, a P/E ratio of 41.11, a price-to-earnings-growth ratio of 1.43 and a beta of 1.20.
Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, February 1st. The industrial products company reported $0.76 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.76. Xylem had a net margin of 7.03% and a return on equity of 17.95%. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. During the same quarter in the previous year, the firm posted $0.66 earnings per share. The business’s revenue was up 16.6% on a year-over-year basis. equities research analysts expect that Xylem Inc will post 2.91 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Stockholders of record on Thursday, February 15th will be issued a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, February 14th. This is an increase from Xylem’s previous quarterly dividend of $0.18. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.12%. Xylem’s dividend payout ratio (DPR) is 45.90%.
In other news, insider Tomas Brannemo sold 2,260 shares of Xylem stock in a transaction that occurred on Tuesday, December 19th. The shares were sold at an average price of $67.75, for a total value of $153,115.00. Following the sale, the insider now directly owns 10,975 shares in the company, valued at $743,556.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Steven R. Loranger sold 47,712 shares of Xylem stock in a transaction that occurred on Monday, December 18th. The shares were sold at an average price of $68.10, for a total transaction of $3,249,187.20. Following the completion of the sale, the director now owns 68,843 shares in the company, valued at $4,688,208.30. The disclosure for this sale can be found here. Insiders sold 75,455 shares of company stock worth $5,166,873 over the last quarter. 0.75% of the stock is owned by corporate insiders.
Several research analysts recently weighed in on XYL shares. Zacks Investment Research raised shares of Xylem from a “hold” rating to a “buy” rating and set a $80.00 price objective on the stock in a research note on Sunday, January 21st. Canaccord Genuity reissued a “hold” rating and set a $75.00 price objective on shares of Xylem in a research note on Sunday, January 28th. Oppenheimer reissued a “buy” rating on shares of Xylem in a research note on Tuesday, October 31st. Seaport Global Securities reaffirmed a “buy” rating on shares of Xylem in a research note on Wednesday, November 1st. Finally, BMO Capital Markets reaffirmed a “buy” rating and issued a $86.00 price target on shares of Xylem in a research note on Friday, February 2nd. Six analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $70.08.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/18/xylem-inc-xyl-position-trimmed-by-boston-research-management-inc.html.
Xylem Company Profile
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.